CLINICAL PRESENTATION, LABORATORY ANALYSIS AND LINEAR GROWTH IN 50 NEONATES AND YOUNG INFANTS WITH ACUTE MENINGITIS: ONE YEAR EXPERIENCE OF A SINGLE CENTER IN QATAR
DeSanctis2

Clinical presentations, Laboratory analysis and Linear Growth in 50 Neonates and Young Infants with Acute Meningitis: One Year Experience of a Single Center in Qatar

Nadra Abdelmaguid1, Wail Said Seleem1, Ashraf T. Soliman1, Rabie S. Mohamed1, Fawzia M. Elgharbawy1, Haytham Yassin1 and Vincenzo De Sanctis2.

 1 Department of Pediatrics, Hamad Medical Center, Doha, Qatar.
2 Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy .

Correspondence to:  Vincenzo De Sanctis, Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy.

Published: May 1, 2019
Received: December 23, 2018
Accepted: April 11, 2019
Mediterr J Hematol Infect Dis 2019, 11(1): e2019028 DOI 10.4084/MJHID.2019.028

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(
https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Meningitis frequently occurs in neonates and can lead to a number of acute, severe complications and long-term disabilities. Although, long term growth delay and abnormal weight gain appear to be risk factors following an acute attack of both bacterial and aseptic meningitis in children, especially during the fast phase of infantile growth, the long-term effects of acute meningitis occurring during the neonatal and early infantile periods on linear growth (length, weight and head growth) have not fully reported.
Aim of the study: The objective of this study is to describe the clinical presentation of neonates and young infants with acute meningitis with different etiologies and to determine the clinical impact of the effect of acute meningitis on growth parameters.
Material and methods: We analyzed the clinical data and the growth parameters of 50 newborns and young infants (age: 1.6 ± 0.9 months) admitted to our hospital (Al Wakhra Hospital, Department of Pediatrics, Doha, Qatar), between 1-1-2016 to 1-1-2017, with acute meningitis. Anthropometric measurements included weight, length, and head circumference. Length SDS (L-SDS) and body-mass-index (BMI) were calculated and recorded at every clinic visit, every 3 months for 8 ± 2 months.
Results: In this age group of neonates and young infants with acute meningitis fever (84%) and hypoactivity (64%) were the major presenting manifestations. Acute bacterial meningitis (n: 10) was associated with higher morbidity [shock (n: 1), subdural empyema (n: 1) and hydrocephalus (n: 1)]. Cerebrospinal fluid (CSF) examinations showed that infants with bacterial meningitis had significantly higher pleiocytosis of mainly polymorphic leukocytes and protein levels, compared to those with aseptic meningitis.
All infants showed normal linear growth and weight gain during the follow-up period (8 ± 2 months). The annualized growth rate of infants was 25.3 ± 3.5 cm per year. All had normal length standard deviation scores (LSDS) (- 0.2 ± 0.9) and none of them had LSDS < -2. All infants had a normal BMI (16.7 ± 1.8 kg/m2). Head circumference growth was normal in 49/50 infants (43.8 ± 1.8 cm) at 8 ± 2 months. One infant developed hydrocephalus after group B streptococcus (GBS) meningitis. There was no statistical difference in linear growth between infants with aseptic and bacterial meningitis.
Conclusion: Acute bacterial meningitis in newborns and young infants is still associated with considerably high morbidity and complications. Infantile linear growth appears to be normal in all newborns and young infants with both bacterial and aseptic meningitis.



Introduction

Meningitis frequently occurs in neonates and can lead to several acute, severe complications and long-term disabilities. Neonates are at higher risk of meningitis because of immaturity in humoral and cellular immunity, and the absence of specific clinical signs makes a diagnosis of meningitis more difficult in neonates than in older children. The causative organism varies with age, immune function, immunization status, and geographic region.[1,2]
The rate at which the disease develops varies between patients. Those with more fulminant illness will be critically ill within the first 24 hours, leaving a very narrow window of opportunity to deliver life-saving treatment. Therefore, an early diagnosis of neonatal meningitis is essential to reduce mortality and to improve outcomes. Cerebrospinal fluid (CSF) examinations and cultures for bacteria as well as polymerase chain reaction (PCR) for viruses should be obtained prior to administration of treatment.[3,4]
Complications of bacterial meningitis can be divided into systemic and neurologic. Systemic complications, such as septic shock, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and septic or reactive arthritis are usually the consequence of the bacteremia that frequently accompanies meningitis. Acute complications include cerebral edema (vasogenic and cytotoxic), increased intracranial pressure, ventriculitis, cerebritis, hydrocephalus, brain abscess, cerebral infarction, cerebral venous thrombosis, arterial stroke, and subdural effusion or empyema.[5-10]
Mortality and long-term complications in survivors are observed in 10-15% and 20-50%, respectively, depending on the term at diagnosis, type of identified organisms, and delay before treatment. Neurological deficits range from moderate-to-severe disabilities to more subtle problems including visual deficits, middle-ear disease, and cognitive and behavioral impairments. Intracerebral complications should be documented using magnetic resonance imaging.
Several studies of adults have shown that pituitary deficiencies can develop in a considerable proportion of subjects during the acute phase of meningitis or years after the infection has disappeared. Post-meningitis growth hormone (GH) deficiency has been described and confirmed by provocative tests in adults and children.[11-13]
The objective of this study is to describe the clinical presentation, laboratory analysis of neonates and young infants with acute meningitis (with different etiologies) and to determine the outcome of this disease, especially on growth parameters in a tertiary care center in Doha, Qatar.

Patients and Methods

All infants [4 preterms (36, 35, 35 and 28 weeks of gestation)] and 46 full-term newborns and young infants with acute meningitis, of different etiologies, who were primarily seen at Al Wakhra Hospital, Department of Pediatrics, Doha (Qatar), between 1-1-2016 to 1-1-2017 were included in the present study (23 girls and 27 boys, mean age:1.6 ± 0.9 month).
Children with malnutrition, anemia, chronic or systemic disease, and skeletal abnormalities were excluded. Fifty infants, age and sex-matched healthy siblings, were randomly selected to serve as controls for anthropometric data.
The diagnosis of meningitis was based on clinical symptoms and cerebrospinal fluid (CSF) examinations (positive CSF bacterial antigen test, with latex agglutination counter immune electrophoresis, associated with neutrophilic pleocytosis, defined as absolute WBC ≥ 100 cells/mm3, with a decreased glucose level ≤ 40 mg/dL and an increased protein concentration ≥ 60 mg/dL), and cultures for bacteria as well as polymerase chain reaction (PCR) for viruses.
Anthropometric parameters including length (using a standard supine length stadiometer), weight and head circumference were measured during hospitalization and at every clinic visit for 8 ± 2 months, after discharge from the hospital.
Fenton Preterm Growth Chart was used for assessment of growth for preterm infants and WHO growth curves were used for evaluation of growth postnatally. Length and weight measurements were compared with the WHO gender- and age-related curves.[14] The length standard deviation score (Ht-SDS) and body mass index (BMI; expressed in kg/m2) were calculated and compared to the control group.
The research protocol has been approved by the ethical committee of Hamad Medical Center before the study.
Data of patients are reported as mean ± SD. The Student t-test was used to compare variables among the selected groups. Wilcoxon test was used to compare variables when the data were not normally distributed. The linear regression equation was used to investigate a possible correlation between variables. Significance was accepted at p < 0.05.

Results

Bacterial meningitis was diagnosed in 10/50 infants with positive CSF cultures: Group B Streptococcus (GBS) in 4 patients, Escherichia coli in 2 Streptococcus pneumoniae in 2, Streptococcus bovis in 1 and Klebsiella pneumoniae in another patient.
Forty infants had the diagnosis of aseptic meningitis (ASM) because of the presence of clinical manifestations of meningitis with CSF pleocytosis but without bacterial etiology detected in the CSF and/or blood. Of those, CSF virology CPR study diagnosed 19 cases with Enterovirus and 1 case with Adenovirus. ASM without viral identification occurred in 20 infants.
At the time of hospital admission, 42 infants were febrile (> 38° C), four infants suffered from hypothermia (< 36.6°C), and 8 were dehydrated, with serum sodium > 135 mmol/L and urine specific gravity > 1.030.
Four out of 10 infants with bacterial meningitis were delivered by Caesarean section. They had a gestational age of 36 ± 3.7 weeks, birth weight of 2.52 ± 0.29 kg and birth length of 46.6 ± 4.0 cm. Maternal age ranged from 28 to 32 years.
One infant (35 weeks of gestational age with premature rupture of membranes for > 24 h before birth) with a birth-weight of 2.56 kg had early onset meningitis. His mother had received antibiotic therapy for 2 days before delivery. Another infant (28 weeks of gestation), birth weight of 1.9 kg, with respiratory distress syndrome) had early meningitis. All the other 8 infants with bacterial meningitis had late-onset infection. Two infants were small for gestational age (SGA) (weight < the 10th percentile). Their gestational age was 35 and 36 weeks, and birth weight of 2.4 and 1.9 kg, respectively. One infant with GBS presented with status epilepticus and right-sided subdural empyema that responded to treatment with meropenem for 4 weeks. Another infant with GBS meningitis presented with shock (blood pressure < 60 Torr systolic). One infant had the syndrome of inappropriate diuretic hormone (SIADH) (defined as a serum Na concentration < 125 mmol/L and urine specific gravity > 1 .022).
Ten of the 40 infants with aseptic meningitis were delivered by Cesarean section. Maternal age ranged from 25 to 36 years. They had a gestational age of 38.7 ± 1.6 weeks, a birth weight of 3.17 ± 0.53 kg, and a birth length of 49.9 ± 2.5 cm. Only 2 had an early onset disease. One infant had birth-weight = 2 kg). None of their mothers had premature rupture of membranes. Three mothers had a fever during the last trimester of pregnancy and received antibiotics.
During the follow up (8 ± 2 months) none of the infants developed cognitive or motor dysfunction. One infant with Streptococcus pneumoniae meningitis and bacteremia developed hydrocephalus (Table 1).


Table 1 Table 1. Clinical presentations and laboratory analysis in 50 neonates and infants with acute meningitis.

Laboratory showed that infants with bacterial meningitis had marked pleocytosis, with polymorphic leukocytes and protein higher levels than those with aseptic meningitis (Table 2).

Table 2 Table 2. Mean values of CFS components in neonates and infants with aseptic versus bacterial meningitis.

Infants with bacterial meningitis received antibiotics for 18.2 ± 5.9 days.
On admission growth data, including length standard deviation score (L-SDS) and BMI, did not differ from those of healthy controls. During the follow-up, all infants had normal growth velocity and weight gain (BMI: 16.7 ± 1.8 kg/m2). Head circumference growth was normal in 49/50 infants (43.8 ± 1.8 cm) at 8 ± 2 months. One infant developed hydrocephalus after GBS meningitis. There was no statistical difference in linear growth between infants with aseptic and bacterial meningitis (Table 3) No symptoms or signs suggesting thyroid or adrenal defects were present.


Table 3 Table 3. Growth data (mean ± SD) of neonates and infants with aseptic versus bacterial meningitis.

Infants did not have a visual impairment or hearing loss and clinically had normal developmental milestones during the first and second follow up visit as assessed by Pediatricians. We did not have a detailed neurodevelopmental assessment for all of them. Visual and Brainstem Auditory Evoked potential testing was used to evaluate all cases with bacterial meningitis and showed no abnormalities. None of the infants with aseptic meningitis had visual or hearing loss.

Discussion

Aseptic meningitis (including viral meningitis) is the most common infection of the central nervous system (CNS) in the pediatric population, occurring most frequently in children younger than 1 year.[15] In agreement with this view, in our young infants (age: 1.6 ± 0.9 months), aseptic meningitis constituted 80% of cases, while bacterial meningitis was diagnosed in 20 % of them.
In our study, fever (84%), hypoactivity (64%) and irritability (20%) were the most common presenting manifestations. However, the clinical signs of neonatal meningitis can be subtle and nonspecific. Meningitis signs such as convulsions, irritability, bulging fontanel, and nuchal rigidity are often late findings that are associated with poor outcomes.[16]
One infant with bacterial meningitis developed shock at presentation that responded to intensive care measures, another one developed subdural empyema, and a third one developed hydrocephalus. These complications confirm the high morbidity (30%) associated with bacterial meningitis in this age group of patients. Other studies reported mortality in 10% of affected infants. 20–50% of survivors developed seizures, cognitive deficiencies, motor abnormalities, and hearing and visual impairments.[17-22]
All our infants had normal length and weight gain during the follow-up period of early infancy (not growth hormone (GH) dependent). No symptoms or signs suggested thyroid or adrenal defects. However, the fact that the young infants with meningitis in this study seemed to be completely “normal” with regards to length and weight may not be representative of infants with meningitis in other regions of the world. Long term growth delay and abnormal weight gain appear to be risk factors following an acute attack of both bacterial and aseptic meningitis in children especially during the fast phase of infantile growth.[23] Potentially, the inflammatory process associated with meningitis may involve the hypothalamic-pituitary area. Isolated and combined pituitary deficiencies, has been shown to develop in a considerable proportion of patients following acute infectious meningitis. These deficiencies may be either transient or permanent and may occur immediately or a few months later.[24-25] Therefore, despite normal linear growth of our infants with meningitis during the first year of their life (not GH dependent) it is necessary to keep monitoring their growth during the childhood period (GH dependent period).
A limitation of the study is represented by the heterogeneous etiology of the cases as well as by the fact that only patient presented with status epilepticus and right-sided subdural empyema. It could be possible that in complicated cases as tuberculous meningitis or in the presence of severe neurologic deterioration the results could be different. However, this population may offer opportunities for clinical observations in comparison with a similar population(s). Additionally, the delayed negative effect on linear growth still form a risk, and the growth of these children should be monitored periodically.

Conclusions

Bacterial meningitis in early infancy is still associated with significant morbidity. However, our study showed normal linear growth and weight gain during the first 8 ± 2 months following treatment of infants with bacterial and aseptic meningitis. Long term follow-up for developing growth delay and delayed neurological sequelae is recommended. Invasive assessments should be reserved for selected cases where there is slow growth or another clinical suspicion of hypopituitarism.

References   

  1. Barichello T,  Fagundes  GD,  Generoso  JS,  Elias  SG,   Simões  LR, Teixeira AL. Pathophysiology of neonatal acute bacterial meningitis. J Med Microbiol. 2013; 62:1781-1789. https://doi.org/10.1099/jmm.0.059840-0  PMid:23946474
  2. Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial Meningitis in infants. Clin Perinatol. 2014;42:29-45. https://doi.org/10.1016/j.clp.2014.10.004  PMid:25677995 PMCid:PMC4332563
  3. Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN, Anthony M, Ninis N, Heath PT; neoMen Study Group. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014;59:e150-157. https://doi.org/10.1093/cid/ciu514  PMid:24997051
  4. Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team 4 million neonatal deaths: when? where? why? Lancet. 2005; 365:891-900. https://doi.org/10.1016/S0140-6736(05)71048-5
  5. Tunkel AR, Hrtman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley R: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004, 39:1267-1284. https://doi.org/10.1086/425368  PMid:15494903
  6. Baud O, Aujard Y. Neonatal bacterial meningitis. Handb Clin Neurol. 2013;112:1109-1113. https://doi.org/10.1016/B978-0-444-52910-7.00030-1  PMid:23622318
  7. Berardi A, Lugli L, Rossi C, China MC, Vellani G, Contiero R, Calanca F, Camerlo F, Casula F, Di Carlo C, Rossi MR, Chiarabini R, Ferrari M, Minniti S, Venturelli C, Silvestrini D, Dodi I, Zucchini A, Ferrari F; Infezioni da Streptococco B Della Regione Emilia Romagna Neonatal bacterial meningitis. Minerva Pediatr. 2010;62 (Suppl 1):51-54. PMid:21089719
  8. Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2014; 26: 635-55. https://doi.org/10.1016/j.ncl.2008.03.003  PMid:18657719 PMCid:PMC2728900
  9. Edwards M. Postnatal Bacterial Infections. In: Martin RJ, Fanaroff AA, Walsh MC, Editors. Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. 9th edition. Philadelphia: Saunders/Elsevier; 2011. p. 793-830. PMCid:PMC3167921
  10. Schaefer S, Boergershausen N, Meyer S, Ivan D, Schepelmann K, Kann PH. Hypothalamic-pituitary insufficiency following infectious disease of the central nervous system. Eur J Endocrinol. 2008;158:3-9. https://doi.org/10.1530/EJE-07-0484  PMid:18166811
  11. Tsiakalos A, Xynos ID, Sipsas NV, Kaltsas G. Pituitary insufficiency after infectious meningitis: a prospective study. J Clin Endocrinol Metab 2010;95:3277-3281. https://doi.org/10.1210/jc.2010-0144  PMid:20427491
  12. Karadag-Oncel E, Cakir M, Kara A, Gonc N, Cengiz AB, Ozon A, Ciftci E, Alikasifoglu A, Ceyhan M, Kandemir N. Evaluation of hypothalamic-pituitary function in children following acute bacterial meningitis. Pituitary. 2015;18:1-7. https://doi.org/10.1007/s11102-013-0547-4  PMid:24356781
  13. Heath PT, Okike IO, Oeser C. Neonatal meningitis: can we do better? Adv Exp Med Biol. 2011; 719:11-24. https://doi.org/10.1007/978-1-4614-0204-6_2  PMid:22125031
  14. de Onis M, Garza C, Victora CG, Onyango AW, Frongillo EA, Martines J. The WHO Multicentre Growth Reference Study: planning, study design, and methodology. Food Nutr Bull. 2004;25: s15-26. https://doi.org/10.1177/15648265040251S104
  15. Sahu RN, Kumar R, Mahapatra AK. Central nervous system infection in the pediatric population. J Pediatr Neurosci. 2009;4:20-24. https://doi.org/10.4103/1817-1745.49102 PMid:21887170 PMCid:PMC3162832
  16. de Louvois J. Acute bacterial meningitis in the newborn. J Antimicrob Chemother. 1994;34 (Suppl A):61-73. https://doi.org/10.1093/jac/34.suppl_A.61  PMid:7844075
  17. Renier D, Flandin C, Hirsch E, Hirsch JF . Brain abscesses in neonates. A study of 30 cases. J Neurosurg.1988;69:877-882. https://doi.org/10.3171/jns.1988.69.6.0877 PMid:3057126
  18. van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Sipahi OR, Brouwer MC; ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22 (Suppl 3):S37-62. https://doi.org/10.1016/j.cmi.2016.01.007  PMid:27062097
  19. Hsu MH, Hsu JF, Kuo HC, Lai MY, Chiang MC, Lin YJ, Huang HR, Chu SM, Tsai MH. Neurological Complications in Young Infants With Acute Bacterial Meningitis. Front Neurol. 2018;9:903. https://doi.org/10.3389/fneur.2018.00903
  20. Chatue Kamga HB. Neuroimaging Complication of Neonatal Meningitis in Full-Term and Near-Term Newborns: A Retrospective Study of One Center. Glob Pediatr Health. 2016;3: 2333794X16681673. https://doi.org/10.1177/2333794X16681673
  21. Littwin B, Pomiećko A, Stępień-Roman M, Spârchez Z, Kosiak W. Bacterial meningitis in neonates and infants - the sonographic picture. J Ultrason. 2018;18:63-70. https://doi.org/10.15557/JoU.2018.0010  PMid:29844943 PMCid:PMC5911721
  22. Mann K, Jackson MA. Meningitis. Pediatr Rev. 2008; 29:417-429. https://doi.org/10.1542/pir.29-12-417  PMid:19047432
  23. Seleem WS, Soliman A, Elawwa A. Linear growth in children after acute meningitis: A controlled study. J Infect Dis Imm. 2012:4:41-45. https://doi.org/10.5897/JIDI12.010
  24. Tanriverdi F, Alp E, Demiraslan H, Dokmetas HS, Unluhizarci K, Doganay M, Casanueva FF, Kelestimur FJ . Investigation of pituitary functions in patients with acute meningitis: a pilot study. Endocrinol Invest. 2008; 6:489-491. https://doi.org/10.1007/BF03346395  PMid:18591878
  25. Tsiakalos A, Xynos I, Sipsa N, Kaltsas G. Pituitary Insufficiency Following Acute Infectious Meningitis: a Prospective Study. Abstract 973, 48th IDSA meeting, Vancouver 2010, October 21-24.

[TOP]